Design of modified U1i molecules against HIV-1 RNA.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Antiviral Research

• Publication date

  2012-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.antiviral.2012.03.010PMID 22507247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The HIV-1 Tat Protein Has a Versatile Role in Activating Viral Transcription

  2011influential reference
• AAV-mediated in vivo knockdown of luciferase using combinatorial RNAi and U1i

  2011influential reference
• Excessive RNA Splicing and Inhibition of HIV-1 Replication Induced by Modified U1 Small Nuclear RNAs

  2010cited by this paper
• RNA-Based Gene Therapy for HIV with Lentiviral Vector–Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma

  2010cited by this paper
• Combination of RNA interference and U1 inhibition leads to increased inhibition of gene expression

  2010influential reference
• Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2-/-γc-/-) mouse model

  2009cited by this paper
• Therapeutic strategy to rescue mutation‐induced exon skipping in rhodopsin by adaptation of U1 snRNA

  2009cited by this paper
• Combinatorial RNAi Against HIV-1 Using Extended Short Hairpin RNAs

  2009influential reference
• Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.

  2009cited by this paper
• Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition

  2008cited by this paper
• Chapter 13:Development of an RNAi-Based Gene Therapy against HIV-1

  2008influential reference
• Requirements for gene silencing mediated by U1 snRNA binding to a target sequence

  2008influential reference
• Reduction of human chorionic gonadotropin beta subunit expression by modified U1 snRNA caused apoptosis in cervical cancer cells

  2008cited by this paper
• U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency.

  2008cited by this paper
• Development of an RNAi based gene therapy against HIV-1

  2007influential reference
• Safety and efficacy of a lentiviral vector containing three anti-HIV genes--CCR5 ribozyme, tat-rev siRNA, and TAR decoy--in SCID-hu mouse-derived T cells.

  2007cited by this paper
• Safety and Efficacy of a Lentiviral Vector Containing Three Anti-HIV Genes-CCR5 Ribozyme, Tat-rev siRNA, and TAR Decoy-in SCID-hu Mouse-Derived T Cells.

  2007cited by this paper
• Use of modified U1 snRNAs to inhibit HIV-1 replication

  2006influential reference
• Optimization of the Tet-On system for regulated gene expression through viral evolution

  2006cited by this paper
• Factor correction as a tool to eliminate between-session variation in replicate experiments: application to molecular biology and retrovirology

  2006cited by this paper
• Silencing of HIV-1 with RNA interference: a multiple shRNA approach.

  2006influential reference
• Focusing the immune response on the V3 loop of HIV-1 gp120 induces cross-clade neutralizing

  2006cited by this paper
• The retrovirus RNA trafficking granule: from birth to maturity

  2006cited by this paper
• Gene transfer in humans using a conditionally replicating lentiviral vector

  2006cited by this paper
• Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter region

  2005cited by this paper
• Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy.

  2005cited by this paper
• Small Interfering RNA-Induced Transcriptional Gene Silencing in Human Cells

  2004cited by this paper
• Modified U1 snRNA suppresses expression of a targeted endogenous RNA by inhibiting polyadenylation of the transcript.

  2004cited by this paper
• Small Interfering RNA-Induced Transcriptional Gene Silencing in Human Cells

  2004cited by this paper
• Safe two‐plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one‐step protocol

  2004cited by this paper
• Human Immunodeficiency Virus Type 1 Subtypes Have a Distinct Long Terminal Repeat That Determines the Replication Rate in a Host-Cell-Specific Manner

  2004cited by this paper
• Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). 1983.

  2004cited by this paper
• Antisense-Mediated Inhibition of Human Immunodeficiency Virus (HIV) Replication by Use of an HIV Type 1-Based Vector Results in Severely Attenuated Mutants Incapable of Developing Resistance

  2004cited by this paper
• Binding specificity determinants of U1A and U2B″ proteins

  2004cited by this paper
• Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages.

  2003cited by this paper
• Inhibiting expression of specific genes in mammalian cells with 5′ end-mutated U1 small nuclear RNAs targeted to terminal exons of pre-mRNA

  2003influential reference
• U1 snRNA associates with TFIIH and regulates transcriptional initiation

  2002cited by this paper
• Hyperstable U1snRNA complementary to the K-ras transcripts induces cell death in pancreatic cancer cells

  2002cited by this paper
• Efficient Human Immunodeficiency Virus Replication Requires a Fine-Tuned Level of Transcription

  2002cited by this paper
• Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes.

  2002cited by this paper
• In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies

  2001cited by this paper
• Lentivirus Vectors Encoding Both Central Polypurine Tract and Posttranscriptional Regulatory Element Provide Enhanced Transduction and Transgene Expression

  2001cited by this paper
• Reduction of Target Gene Expression by a Modified U1 snRNA

  2001cited by this paper
• Functional Differences between the Long Terminal Repeat Transcriptional Promoters of Human Immunodeficiency Virus Type 1 Subtypes A through G

  2000cited by this paper
• U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase.

  1998cited by this paper
• Protein functions in pre-mRNA splicing.

  1997cited by this paper
• Involvement of U1 Small Nuclear Ribonucleoproteins (snRNP) in 5′ Splice Site-U1 snRNP Interaction*

  1996cited by this paper
• Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity

  1993cited by this paper
• Exon definition may facilitate splice site selection in RNAs with multiple exons.

  1990cited by this paper
• Identification of the RNA binding segment of human U1 A protein and definition of its binding site on U1 snRNA.

  1989cited by this paper
• A common RNA recognition motif identified within a defined U1 RNA binding domain of the 70K U1 snRNP protein.

  1989cited by this paper
• Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

  1983cited by this paper

• The discovery and development of RNA-based therapies for treatment of HIV-1 infection

  2022cites this paper
• Could gene therapy cure HIV?

  2021cites this paper
• Therapeutic approaches to treat human spliceosomal diseases.

  2019cites this paper
• A U1i RNA that Enhances HIV-1 RNA Splicing with an Elongated Recognition Domain Is an Optimal Candidate for Combination HIV-1 Gene Therapy

  2019influential citation
• Nucleotide Modifications Decrease Innate Immune Response Induced by Synthetic Analogs of snRNAs and snoRNAs

  2018cites this paper
• Potential mechanisms for cell-based gene therapy to treat HIV/AIDS

  2015cites this paper
• U1 interference (U1i) for antiviral approaches.

  2015cites this paper
• U1 snRNP control of 3'-end processing and the therapeutic application of U1 inhibition combined with RNA interference.

  2013cites this paper
• Putting an ‘End’ to HIV mRNAs: capping and polyadenylation as potential therapeutic targets

  2013cites this paper
• On the role of four small hairpins in the HIV-1 RNA genome

  2013cites this paper
• RNAi as Antiviral Therapy: The HIV-1 Case

  2013cites this paper
• Chemical Synthesis of U1 snRNA Derivatives

  2013cites this paper